they wont make money for a few years yet, and they seem able to raise cash easy enough when required, 8 quid is peanuts,it could get there just on positive data, or certainly on FDA approval, thats why i dont understand why folk want a buy out... unless they dont believe that gw will ever generate a profit? imo it will be a few years yet, but should happen, 2020 seems to be the best bet based on analysts predictions.
lets pretend GW get a hit with Glioma, it would be massive, and far surpass any of the current PT's, or a buy out within the next year.
But they are not making any money at mo just creating loads of debt , if a trial or two goes wrong it could mean major probs , so of a big company came in at 8 quid it would be worth taking surely ! Just my thoughts
imo, not for a while yet, and if it was it would be a disaster, gw has a huge potential pipeline, why do peeps want a takeover that generates what..10%? 20 % rise? we get that through normal trading.. i dont understand the desire, or why peeps put it out as something good. GW are completely focussed on selling Epidiolex without a partner, and imo they are smart to do so, as long as they can get the numbers that they claim.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.